[1]
Borghese, O. and Vincenzoni, C. 2024. Commentary on “Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial”. Bleeding, Thrombosis and Vascular Biology. 3, 2 (Jun. 2024). DOI:https://doi.org/10.4081/btvb.2024.141.